Medicines Formulary - search results for ""

Search results for ""

Drug name	NICE TAs	Comments	Subchapter
Ceritinib	TA500 - Ceritinib for untreated ALK-positive non-small-cell lung cancer TA395 - Ceritinib for previously treated anaplastic lymphoma kinase positive non-small-cell lung cancer	For hospital use only	8.1
Certolizumab injection	TA186 - Rheumatoid arthritis - Certolizumab pegol TA375 - Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed TA574 - Certolizumab pegol for treating moderate to severe plaque psoriasis	Hospital use only	10.1
Cerumol ear drops		Contains arachis (peanut) oil	12.1
Cetaphen 10% topical ointment			13.7
Cetirizine			3.4
Cetraben® emollient cream			13.2
Cetrorelix injection			6.6
Cetuximab infusion	TA172 - Cetuximab for the treatment of recurrent and/or metastatic squamous cell cancer of the head and neck TA145 - Cetuximab for the treatment of locally advanced squamous cell cancer of the head and neck TA439 - Cetuximab and panitumumab for previously untreated metastatic colorectal cancer TA118 - Bevacizumab and cetuximab for the treatment of metastatic colorectal cancer TA473 - Cetuximab for treating recurrent or metastatic squamous cell cancer of the head and neck	National CDF list. For hospital use only.	8.1
Chenodeoxycholic acid capsules		Clinical Commissioning policy: Cholic acid and Chenodeoxycholic acid for treating inborn errors of bile and synthesis (all ages) (PDF)	1.9
Chloral hydrate solution			4.1

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
Next page
Last page

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.